MONSEY, N.Y., June 28, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether Elanco Animal Health Incorporated (NYSE:ELAN) (“Elanco”) has violated federal securities laws after the company announced that the U.S. label for its new eczema treatment for dogs, Zenrelia, will include an unexpected boxed warning on safety. Elanco also announced a delay in the launch of Zenrelia to the fourth quarter. Upon this news, Elanco shares fell over 20% in trading on June 27, 2024. If you a ...